Remote loading paclitaxel–doxorubicin prodrug into liposomes for cancer combination therapy

The combination of paclitaxel (PTX) and doxorubicin (DOX) has been widely used in the clinic. However, it remains unsatisfied due to the generation of severe toxicity. Previously, we have successfully synthesized a prodrug PTX-S-DOX (PSD). The prodrug displayed comparable in vitro cytotoxicity compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jiang, Wang, Yingli, Zhou, Shuang, Li, Jinbo, Wang, Jiamei, Chi, Dongxu, Wang, Xue, Lin, Guimei, He, Zhonggui, Wang, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564015/
https://www.ncbi.nlm.nih.gov/pubmed/33088692
http://dx.doi.org/10.1016/j.apsb.2020.04.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564015/
https://www.ncbi.nlm.nih.gov/pubmed/33088692
http://dx.doi.org/10.1016/j.apsb.2020.04.011

Ejemplares similares